We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Respiratory Medicine

Journal Scan / Research · November 03, 2019

Vasopressin vs Norepinephrine for the Management of Septic Shock in Cancer Patients

Critical Care Medicine


Additional Info

Disclosure statements are available on the authors' profiles:

Critical Care Medicine
Vasopressin Versus Norepinephrine for the Management of Septic Shock in Cancer Patients: The VANCS II Randomized Clinical Trial
Crit. Care Med. 2019 Oct 14;[EPub Ahead of Print], LA Hajjar, C Zambolim, A Belletti, JP de Almeida, AC Gordon, G Oliveira, CHL Park, JT Fukushima, SI Rizk, TF Szeles, NC Dos Santos Neto, RK Filho, FRBG Galas, G Landoni

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading